Opportunities to identify FGM are frequently missed. Measures should be taken to improve FGM diagnosis and care.

Routine obstetric follow-up combined with specialized care for women with FGM, including defibulation, can avoid inappropriate obstetric practices and reduce obstetric complications known to be associated with FGM.

Medical and health sciences are disciplines of paramount importance in academia. Universities face a crucial challenge in training qualified health experts for teaching and research in these disciplines. With the globalization of the higher education system, international university ranking systems are an increasingly used tool to assess the excellence of universities and help students and researchers to choose an institution. We conduct a scoping review using Web of Science and Google Scholar to search for scientific literature written in English, published between January 2019 and March 2022. We aim to understand to what extent international university ranking systems are adapted to the disciplines of medical and health sciences. We select any scientific article addressing international university ranking systems and their indicators or proposing a new international university ranking system or new indicators. We include a total of 55 articles. Among them, 10 articles propose a new university ranking system, nine propose a new method to analyze or improve existing international university ranking systems, three propose new indicator(s), and two propose a new database. Almost all articles include an analysis of existing rankings. We find no article that specifically addresses the ranking of schools of medical or health sciences. This scoping review highlights the absence of a specific international university ranking system designed for the disciplines of medical and health sciences. Future researchers could investigate how to develop discipline-specific indicators and promote a university ranking system dedicated to these disciplines.

No study has yet investigated if a severe SARS-CoV-2 infection represents a marker of an undiagnosed cancer. This population-based study, using the SNDS database, identified from 02/15/2020 to 08/31/2021, 41,302 individuals hospitalized in intensive care unit due to SARS-CoV-2 (ICU-gr) and 713,670 control individuals not hospitalized for SARS-CoV-2 (C-gr). Individuals were matched according to year of birth, sex and French department. The cancer incidence was compared in the two groups during the follow-up period (index date-12/31/2021), using Cox proportional hazards models adjusted on matching variables, socioeconomic characteristics and comorbidities. In the ICU-gr, 2.2% (n = 897) was diagnosed with a cancer in the following months, compared to 1.5% (n = 10,944) in the C-gr. The ICU-gr had a 1.31 higher risk of being diagnosed with a cancer following hospital discharge compared to the C-gr (aHR 1.31, 95% CI 1.22–1.41). A global similar trend was found when competing risk of death was taken into account (aHR 1.25, 95% CI 1.16–1.34). A significant higher risk was found concerning renal (aHR 3.16, 95% CI 2.33–4.27), hematological (aHR 2.54, 95% CI 2.07–3.12), colon (aHR 1.72, 95% CI 1.34–2.21), and lung (aHR 1.70, 95% CI 1.39–2.08) cancers. This suggests that a severe SARS-CoV-2 infection may represent a marker of an undiagnosed cancer.

No abstract